โณ Fetching live dividend data...
Home โบ Calculator โบ AZN Dividend Calculator 2026
AstraZeneca PLC ยท NYSE
Price: $174.35 ยท Annual div: $3.23/share ยท Frequency: semi-annual ยท Payout ratio: 49% ยท Ex-div: 2026-08-07
At $10,000, AZN pays $184.11/yr ($15.34/mo avg, semi-annual). Combine with your other stocks to see your 12-month paycheck & next 60 days of payouts.
Get an email 7 days before AZN goes ex-dividend (exact payout + last day to buy under T+1) and the day the dividend is raised, cut or suspended.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-08-07Latest | 2026-09-08 | $1.0600 | 2.70% | $157.97 |
| 2026-02-20 | 2026-03-23 | $2.1700 | 2.83% | $188.41 |
| 2025-08-08 | 2025-09-08 | $1.0300 | 2.82% | $147.50 |
| 2025-02-21 | 2025-03-24 | $2.1281 | 2.20% | $141.90 |
| 2024-08-09 | 2024-09-09 | $1.0000 | 1.85% | $160.60 |
| 2024-02-22 | 2024-03-25 | $1.9700 | 3.69% | $132.12 |
| 2023-08-10 | 2023-09-11 | $0.9300 | 2.68% | $142.85 |
| 2023-02-23 | 2023-03-27 | $1.9700 | 3.82% | $127.46 |
| 2022-08-11 | 2022-09-12 | $0.9318 | 2.86% | $132.64 |
| 2022-02-24 | 2022-03-28 | $1.9700 | 4.13% | $116.50 |
| 2021-08-12 | 2021-09-13 | $0.8965 | 3.25% | $115.33 |
| 2021-02-25 | 2021-03-29 | $1.9418 | 4.72% | $100.48 |
| 2020-08-13 | 2020-09-14 | $0.9114 | โ | โ |
| 2020-02-27 | 2020-03-30 | $1.8847 | โ | โ |
| 2019-08-08 | 2019-09-09 | $0.8724 | โ | โ |
| 2019-02-28 | 2019-03-27 | $1.9000 | โ | โ |
| 2018-08-09 | 2018-09-10 | $0.9000 | โ | โ |
| 2018-02-15 | 2018-03-19 | $1.9000 | โ | โ |
| 2017-08-09 | 2017-09-11 | $0.9000 | โ | โ |
| 2017-02-15 | 2017-03-20 | $1.9000 | โ | โ |
| 2016-08-10 | 2016-09-12 | $0.9000 | โ | โ |
| 2016-02-17 | 2016-03-21 | $1.9000 | โ | โ |
| 2015-08-12 | 2015-09-14 | $0.9000 | โ | โ |
| 2015-02-18 | 2015-03-23 | $1.9000 | โ | โ |
| 2014-08-13 | 2014-09-15 | $0.9000 | โ | โ |
| 2014-02-19 | 2014-03-24 | $1.9000 | โ | โ |
| 2013-08-14 | 2013-09-16 | $0.9000 | โ | โ |
| 2013-02-13 | 2013-03-18 | $1.9000 | โ | โ |
| 2012-08-08 | 2012-09-10 | $0.9000 | โ | โ |
| 2012-02-15 | 2012-03-19 | $1.9500 | โ | โ |
| 2011-08-04 | 2011-09-12 | $0.8500 | โ | โ |
| 2011-02-02 | 2011-03-14 | $1.8500 | โ | โ |
| 2010-08-04 | 2010-09-13 | $0.7000 | โ | โ |
| 2010-02-03 | 2010-03-15 | $1.7100 | โ | โ |
| 2009-08-05 | 2009-09-14 | $0.5900 | โ | โ |
| 2009-02-04 | 2009-03-16 | $1.5000 | โ | โ |
| 2008-08-06 | 2008-09-15 | $0.5500 | โ | โ |
| 2008-02-07 | 2008-03-17 | $1.3500 | โ | โ |
| 2007-08-08 | 2007-09-17 | $0.5200 | โ | โ |
| 2007-02-07 | 2007-03-19 | $1.2300 | โ | โ |
| 2006-08-09 | 2006-09-18 | $0.4900 | โ | โ |
| 2006-02-08 | 2006-03-20 | $0.9200 | โ | โ |
| 2005-08-10 | 2005-09-19 | $0.3800 | โ | โ |
| 2005-02-09 | 2005-03-21 | $0.6450 | โ | โ |
| 2004-08-11 | 2004-09-20 | $0.2950 | โ | โ |
| 2004-02-18 | 2004-04-06 | $0.5400 | โ | โ |
| 2003-08-20 | 2003-10-06 | $0.2550 | โ | โ |
| 2003-02-19 | 2003-04-07 | $0.5222 | โ | โ |
| 2002-08-21 | 2002-10-07 | $0.2555 | โ | โ |
| 2002-02-20 | 2002-04-08 | $0.5222 | โ | โ |
| 2001-08-22 | 2001-10-05 | $0.2555 | โ | โ |
| 2001-02-21 | 2001-04-09 | $0.5222 | โ | โ |
| 2000-11-14 | โ | $1.0730 | โ | โ |
| 2000-09-06 | 2000-10-23 | $0.2555 | โ | โ |
| 2000-03-08 | 2000-04-17 | $0.5222 | โ | โ |
| 1999-09-08 | 1999-10-25 | $0.2555 | โ | โ |
| 1999-04-07 | 1999-04-28 | $0.4956 | โ | โ |
| 1998-09-16 | โ | $0.2830 | โ | โ |
| 1998-03-18 | โ | $0.5120 | โ | โ |
| 1997-09-17 | โ | $0.2663 | โ | โ |
| 1997-03-19 | โ | $0.4473 | โ | โ |
| 1996-09-20 | โ | $0.2407 | โ | โ |
| 1996-03-22 | โ | $0.2533 | โ | โ |
| 1995-09-22 | โ | $0.2237 | โ | โ |
| 1995-03-24 | โ | $0.3507 | โ | โ |
| 1994-09-23 | โ | $0.2053 | โ | โ |
| 1994-03-18 | โ | $0.3143 | โ | โ |
| 1993-09-24 | โ | $0.1930 | โ | โ |
AstraZeneca PLC operates as a biopharmaceutical company, specializing in the discovery, development, manufacturing, and commercialization of prescription medications. Its comprehensive portfolio addresses diverse therapeutic areas. In oncology, key marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. For cardiovascular, renal, and metabolism diseases, the company offers treatments such as Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR. Respiratory and immunology conditions are targeted by products like Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris. Additionally, rare diseases are treated with Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris. The company's product offerings also extend to Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for influenza; Seroquel IR/Seroquel XR for schizophrenia and bipolar disorder; Nexium and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for COVID-19. AstraZeneca serves primary and specialty care physicians globally, leveraging a network of distributors and local representative offices across the United Kingdom, the rest of Europe, the Americas, Asia, Africa, and Australasia. Strategic collaboration forms a vital component of its operations. Partnerships include an agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG for the development and commercialization of NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for transthyretin amyloidosis; Proteros Biostructures GmbH for the joint discovery of novel small molecules targeting hematological cancers; and Sierra Oncology, Inc. for the development and commercialization of AZD5153. Initially incorporated in 1992 as Zeneca Group PLC, the company adopted its current name, AstraZeneca PLC, in April 1999. It is headquartered in Cambridge, United Kingdom.
Forward dividend yield from the latest data ยท open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
One email when it matters โ before AZN goes ex-dividend, and the day the payout is raised, cut or suspended.
All four US brokers below offer $0 stock/ETF commissions and free fractional dividend reinvestment (DRIP).
Real after-tax yield depends on where you live and how you hold AZN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| ๐บ๐ธ Roth IRA / 401k | 0% | 1.85% | -0.95% | $185 / yr |
| ๐บ๐ธ US Taxable (15%) โ | 15% | 1.57% | -1.23% | $157 / yr |
| ๐บ๐ธ US Taxable (20%) | 20% | 1.48% | -1.32% | $148 / yr |
| ๐ฌ๐ง UK ISA | 0% | 1.85% | -0.95% | $185 / yr |
| ๐ฌ๐ง UK Taxable | 8.75% | 1.69% | -1.11% | $169 / yr |
| ๐จ๐ฆ TFSA | 0% | 1.85% | -0.95% | $185 / yr |
| ๐จ๐ฆ CA Taxable | 25% | 1.39% | -1.41% | $139 / yr |
| ๐ฆ๐บ Super (pension) | 15% | 1.57% | -1.23% | $157 / yr |
| ๐ฆ๐บ AU Taxable | 30% | 1.29% | -1.50% | $130 / yr |
| ๐ฉ๐ช DE Taxable | 26.375% | 1.36% | -1.44% | $136 / yr |
| ๐ซ๐ท FR Taxable | 30% | 1.29% | -1.50% | $130 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $3.23/share/yr ยท ๐บ๐ธ US Taxable (15%) ยท static projection (no growth assumed).
AZN pays quarterly โ 4 times per year. Ex-div: 2026-08-07.
How AZN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024โ2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AZN sourced from FMP /financial-growth endpoint โ real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-11-06 | 1 | $186.24 | $186.00 | ||
| A-Award | 2026-10-06 | 2 | $159.80 | $320.00 | ||
| A-Award | 2026-09-08 | 1 | $162.60 | $163.00 | ||
| Buy | 2026-08-08 | 20.233 | $160.57 | $3.2K | ||
| A-Award | 2026-08-06 | 2 | $163.34 | $327.00 | ||
| A-Award | 2026-07-06 | 2 | $190.43 | $381.00 | ||
| A-Award | 2026-06-08 | 1 | $179.75 | $180.00 | ||
| Sale | 2026-05-20 | 11,893 | $185.78 | $2.21M | ||
| A-Award | 2026-05-06 | 1 | $186.28 | $186.00 | ||
| A-Award | 2026-04-07 | 1 | $196.03 | $196.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Compare AZN with peers: AZN vs ABBV ยท AZN vs AMGN ยท AZN vs BMY
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores โ lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AZN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer โ
AstraZeneca PLC (AZN) is currently trading at $174.35, 18% below its 52-week high. The current dividend yield is 1.85% based on an annual payout of $3.23 per share.
AstraZeneca PLC (AZN) is a healthcare stock currently trading at $174.35 with a dividend yield of 1.85%. It pays an annual dividend of $3.23 per share. The payout ratio of 49% suggests the dividend is well-covered by earnings. Over the past 5 years, AZN has grown its dividend at a compound annual rate of 3.3%.
Auto-generated from live market data. For educational purposes only โ not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team โ not customer reviews.
AZN (AstraZeneca PLC) has a dividend yield of 1.85%, based on an annual dividend of $3.23 per share and a price of $174.35. Over the last 12 months it paid $3.23 per share โ a trailing yield of 1.85%. Dividends are paid semi-annual.
Yield history: over the last 12 payments, AZN's 12-month yield ranged from 1.85% to 4.72%. Full AZN dividend history โ
Yield on cost: if AZN's dividend keeps growing 3.5% a year, a purchase at today's price would yield 2.20% after 5 years, 2.61% after 10 years and 3.69% after 20 years on the original investment.
With dividends reinvested, a AZN position grows its share count by about 1.69% in the first year at today's price and yield.
| Year | Shares bought by dividends | Total shares | Dividend income | Position value | Yield on cost |
|---|---|---|---|---|---|
| 1 | 0.97 | 58.32 | $192 | $11,542 | 1.92% |
| 3 | 0.83 | 60.06 | $212 | $15,310 | 2.12% |
| 5 | 0.71 | 61.54 | $233 | $20,208 | 2.33% |
| 10 | 0.47 | 64.33 | $291 | $39,794 | 2.91% |
| 20 | 0.20 | 67.35 | $432 | $147,799 | 4.32% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work โ
AZN (AstraZeneca PLC) has a dividend yield of 1.85%, based on an annual dividend of $3.23 per share and a price of $174.35. Over the last 12 months it paid $3.23 per share โ a trailing yield of 1.85%. Dividends are paid semi-annual.
$10,000 in AZN at a 1.85% yield pays about $185 a year ($15 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a AZN position grows its share count by about 1.69% in the first year at today's price and yield.
Enter your starting amount, monthly contribution and time horizon in the AZN DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
AZN's next ex-dividend date has not been announced yet; the most recent one was 2026-08-07. AZN pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
AZN's dividend changed 2.3% over the last year and 3.3% a year on average over five years.
AZN pays out 49% of its earnings as dividends. A payout ratio under 60% is generally considered sustainable. Dividends can be cut at any time; this is not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly โ $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot โIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
โฑ๏ธ Takes 30 seconds ยท No signup ยท Free forever